Kevin Mathews's Insider Trades & SAST Disclosures
Kevin Mathews's most recent trade in Acutus Medical Inc was a trade of 6,342 Form 4 done at an average price of $0.2 . Disclosure was reported to the exchange on Jan. 7, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Kevin Mathews.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Acutus Medical Inc | Mathews Kevin | SVP, Commercial | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.19 per share. | 07 Jan 2024 | 6,342 | 61,106 | - | 0.2 | 1,199 | Form 4 |
| Acutus Medical Inc | Kevin Mathews | SVP, Commercial | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.69 per share. | 05 Aug 2023 | 134 | 67,448 | - | 0.7 | 92 | FORM 4 |
| Acutus Medical Inc | Kevin Mathews | SVP, Commercial | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.75 per share. | 01 Apr 2023 | 321 | 66,332 | - | 0.8 | 242 | FORM 4 |
| Acutus Medical Inc | Kevin Mathews | SVP, Commercial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 42,500 | 66,653 | - | 0 | FORM 4 | |
| Acutus Medical Inc | Kevin Mathews | SVP, Commercial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 42,500 | 42,500 | - | - | FORM 4 | |
| Acutus Medical Inc | Kevin Mathews | SVP, Commercial | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.87 per share. | 01 Feb 2023 | 3,540 | 24,153 | - | 1.9 | 6,620 | FORM 4 |
| Acutus Medical Inc | Kevin Mathews | SVP, Global Sales | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.56 per share. | 05 Aug 2022 | 134 | 27,693 | - | 1.6 | 209 | Common Stock |
| Acutus Medical Inc | Kevin Mathews | SVP, Global Sales | Sale or transfer of securities back to the company at price $ 0.00 per share. | 25 Jul 2022 | 21,583 | 35,467 | - | - | Employee Stock Options (Right to Buy) | |
| Acutus Medical Inc | Kevin Mathews | SVP, Global Sales | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2022 | 21,583 | 57,050 | - | - | Employee Stock Options (Right to Buy) | |
| Acutus Medical Inc | Kevin Mathews | SVP, Global Sales | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2022 | 20,000 | 57,050 | - | - | Employee Stock Options (Right to Buy) | |
| Acutus Medical Inc | Kevin Mathews | SVP, Global Sales | Sale or transfer of securities back to the company at price $ 0.00 per share. | 25 Jul 2022 | 20,000 | 37,050 | - | - | Employee Stock Options (Right to Buy) | |
| Acutus Medical Inc | Kevin Mathews | SVP, Global Sales | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2022 | 15,647 | 57,050 | - | - | Employee Stock Options (Right to Buy) | |
| Acutus Medical Inc | Kevin Mathews | SVP, Global Sales | Sale or transfer of securities back to the company at price $ 0.00 per share. | 25 Jul 2022 | 15,467 | 41,583 | - | - | Employee Stock Options (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges